Torrelles J, Chatterjee D
Pathogens. 2023; 12(11).
PMID: 38003746
PMC: 10675199.
DOI: 10.3390/pathogens12111281.
Turner J, Torrelles J
Pathog Dis. 2018; 76(4).
PMID: 29722821
PMC: 5930247.
DOI: 10.1093/femspd/fty026.
Alban S, de Moura J, Minozzo J, Mira M, Soccol V
BMC Infect Dis. 2013; 13:42.
PMID: 23351151
PMC: 3585472.
DOI: 10.1186/1471-2334-13-42.
Pitarque S, Larrouy-Maumus G, Payre B, Jackson M, Puzo G, Nigou J
Tuberculosis (Edinb). 2008; 88(6):560-5.
PMID: 18539533
PMC: 2613510.
DOI: 10.1016/j.tube.2008.04.002.
Marques M, Chitale S, Brennan P, Pessolani M
Infect Immun. 1998; 66(6):2625-31.
PMID: 9596726
PMC: 108248.
DOI: 10.1128/IAI.66.6.2625-2631.1998.
Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S, Shanker Narayan N, Ramu G, Muthukkaruppan V
Clin Exp Immunol. 1994; 96(1):79-85.
PMID: 8149671
PMC: 1534549.
DOI: 10.1111/j.1365-2249.1994.tb06234.x.
New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.
Thomson A, Starzl T
Immunol Rev. 1993; 136:71-98.
PMID: 8132204
PMC: 2972635.
DOI: 10.1111/j.1600-065x.1993.tb00655.x.
Chemical definition, cloning, and expression of the major protein of the leprosy bacillus.
Rivoire B, Pessolani M, Bozic C, Hunter S, Hefta S, Mehra V
Infect Immun. 1994; 62(6):2417-25.
PMID: 7910593
PMC: 186527.
DOI: 10.1128/iai.62.6.2417-2425.1994.
Detection of Mycobacterium leprae infection by PCR.
Wichitwechkarn J, Karnjan S, Shuntawuttisettee S, Sornprasit C, Kampirapap K, Peerapakorn S
J Clin Microbiol. 1995; 33(1):45-9.
PMID: 7699064
PMC: 227877.
DOI: 10.1128/jcm.33.1.45-49.1995.
Phenolic glycolipids of Mycobacterium bovis: new structures and synthesis of a corresponding seroreactive neoglycoprotein.
Chatterjee D, Bozic C, Knisley C, Cho S, Brennan P
Infect Immun. 1989; 57(2):322-30.
PMID: 2643563
PMC: 313100.
DOI: 10.1128/iai.57.2.322-330.1989.
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.
Moreno C, Taverne J, Mehlert A, Bate C, Brealey R, Meager A
Clin Exp Immunol. 1989; 76(2):240-5.
PMID: 2503277
PMC: 1541837.
Generation of monoclonal antibodies to the specific sugar epitopes of Mycobacterium avium complex serovars.
Rivoire B, Ranchoff B, Chatterjee D, Gaylord H, Tsang A, Kolk A
Infect Immun. 1989; 57(10):3147-58.
PMID: 2476400
PMC: 260783.
DOI: 10.1128/iai.57.10.3147-3158.1989.
Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field.
Izumi S, Fujiwara T, Ikeda M, Nishimura Y, Sugiyama K, Kawatsu K
J Clin Microbiol. 1990; 28(3):525-9.
PMID: 2182670
PMC: 269656.
DOI: 10.1128/jcm.28.3.525-529.1990.
Cell wall and membrane changes associated with ethambutol resistance in Mycobacterium tuberculosis H37Ra.
Sareen M, Khuller G
Antimicrob Agents Chemother. 1990; 34(9):1773-6.
PMID: 2126690
PMC: 171922.
DOI: 10.1128/AAC.34.9.1773.
Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes.
Schlesinger L, Horwitz M
J Exp Med. 1991; 174(5):1031-8.
PMID: 1940785
PMC: 2118995.
DOI: 10.1084/jem.174.5.1031.
Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli.
Esaguy N, Aguas A, van Embden J, Silva M
Infect Immun. 1991; 59(3):1117-25.
PMID: 1900057
PMC: 258376.
DOI: 10.1128/iai.59.3.1117-1125.1991.
Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.
Meyers W, Marty A
Drugs. 1991; 41(6):832-56.
PMID: 1715262
DOI: 10.2165/00003495-199141060-00003.
A major immunogenic 36,000-molecular-weight antigen from Mycobacterium leprae contains an immunoreactive region of proline-rich repeats.
Thole J, Stabel L, Suykerbuyk M, de Wit M, Klatser P, Kolk A
Infect Immun. 1990; 58(1):80-7.
PMID: 1688422
PMC: 258411.
DOI: 10.1128/iai.58.1.80-87.1990.
Cellular immune response to the cell walls of Mycobacterium leprae in leprosy patients and healthy subjects exposed to leprosy.
Roche P, Neupane K, Britton W
Clin Exp Immunol. 1992; 89(1):110-4.
PMID: 1628419
PMC: 1554417.
DOI: 10.1111/j.1365-2249.1992.tb06887.x.
Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.
Dhandayuthapani S, Izumi S, Anandan D, Bhatia V
Clin Exp Immunol. 1992; 88(2):253-7.
PMID: 1572088
PMC: 1554298.
DOI: 10.1111/j.1365-2249.1992.tb03069.x.
